Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in rats

BMC Complementary and Alternative Medicine

Volumn 15, Issue 1, 2015, Pages

  Chattopadhyaya, I ^a   Gupta, Sumeet ^a   Mohammed, Asad ^b   Mushtaq, N ^a   Chauhan, S ^a   Ghosh, Saikant ^c  

^a MAHARISHI MARKANDESHWAR DEEMED TO BE UNIVERSITY   (India)

^b SHAQRA UNIVERSITY   (Saudi Arabia)

^c Sun Pharma Advance Research Centre FDD NDDS Lipid Research Group ^*  (India)

Author keywords

Anti oxidant assays; Dopamine level; Rotational behavior; Spirulina

Indexed keywords

AMANTADINE; DOPAMINE; OXIDOPAMINE; SPIRULINA EXTRACT; SPIRULINA FUSIFORM EXTRACT; UNCLASSIFIED DRUG; NEUROPROTECTIVE AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MOVEMENT; CIRCLING BEHAVIOR; CONTROLLED STUDY; CORPUS STRIATUM; LOCOMOTION; MALE; MOTOR COORDINATION; NEUROPROTECTION; NONHUMAN; PARKINSONISM; RAT; SPIRULINA; SPIRULINA FUSIFORM; ANIMAL; CHEMICALLY INDUCED; DIETARY SUPPLEMENT; PATHOPHYSIOLOGY;

AMANTADINE; ANIMALS; DIETARY SUPPLEMENTS; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PARKINSONIAN DISORDERS; RATS; SPIRULINA;

EID: 84939797286     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-015-0815-0     Document Type: Article

References (52)

1. Morais LCSL, Barbosa-Filho JM, Almeida RN. Plants and bioactive compounds for the treatment of Parkinson's disease. Arquivos Brasileiros de Fitomedicina Científica. 2003;1:127-32.
2. Hornykiewicz O. The tropical localization and content of noradrenalin and dopamine (3-hydroxytyramine) in the substantia nigra of normal persons and patients with Parkinson's disease. Wien Klin Wochenschr. 1963;75:309-12.
3. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann NY Acad Sci. 2003;991:1-14.
4. Baluchnejadmojarad T, Roghani M. The Flavonoid Hesperetin Alleviates Behavioral Abnormality in 6-Hydroxydopamine Rat Model of Hemi-Parkinsonism. BCN. 2010;2:20-3.
5. Ahmad M, Saleem S, Ahmad AS. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced Parkinsonism in rats: neurobehavioral. Neurochemical and Immunohistochemical Evidences. J Neurochem. 2005;93:94-104.
6. Koppula S, Kumar Hemant VMS, Wook K. Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease. Int J Mol Sci. 2012;13:10608-29.
7. Devesh C, Mehla K, Nair A, Gupta S. Spirulina reverses histomorphological changes in diabetic osteoporosis in pioglitazone treated rats. J Diabetes Metab. 2012; S1:006. doi: 10.4172/2155-6156.S1-006.
8. Gupta S, Hrishikeshvan HJ, Sehajpal PK. Spirulina protects against Rosiglitazone induced osteoporosis in insulin resistance rats. Diab Res & Clin Pract. 2010;87:38-43.
9. Gupta A, Nair A, Kumria R, Gupta S. Assessment of Pharmacokinetic interaction of spirulina with glitazone in a type 2 diabetes rat model. J Med Food. 2013;16:1095-100.
10. Chu WL, Lim YW, Radhakrishnan AK. Protective effect of aqueous extract from spirulina platensis against cell death induced by free radicals. BMC Complement Altern Med. 2010;10:2-8.
11. Gershwin ME, Belay AE. Spirulina in human nutrition and health. New York: CRC Press Taylor & Francis Group Boca Raton, London; 2008.
12. Kelly Moorhead K, Capelli B, Cysewski GR. SPIRULINA nature's superfood. Hawaii: Cyanotech Corporation; 1993. 1-63.
13. Abdhelkhalek NKM, Ghazy EW, Abdel-Daim MM. Pharmacodynamic interaction of Spirulina platensis and deltamethrin in freshwater fish Nile tilapia, Oreochromis niloticus: impact on lipid peroxidation and oxidative stress. Environ Sci Pollut Res. 2015;22:3023-31.
14. Abdel-Daim MM, Abuzead SAA, Halawa SM. Protective role of spirulina platensis against acute deltamethrin-induced toxicity in rats. PLoS One. 2013;9:e72991.
15. Abdel-Daim MM. Pharmacodynamic interaction of Spirulina platensis with erythromycin in Egyptian Baladi bucks (Capra hirus). Small Rumin Res. 2014;120:234-41.
16. Abdel-Daim MM, Farouk SM, Madkour FF, Azab SS. Anti-inflammatory and immunomodulatory effects of Spirulina platensis in comparison to Dunaliella salina in acetic-induced rat experimental colitis. Immunopharmacol Immunotoxicol. 2015;37:126-39.
17. Stromberg I, Gemma C, Vila J. Blueberry and spirulina-enriched diets enhance striatal dopamine recovery and induce rapid, transient microglia activation after injury of the rat nigrostriatal dopamine system. Exp Neurol. 2005;196:298-307.
18. Bachstetter AD, Jennifer J, Schlunk A. Spirulina promotes stem cell genesis and protects against LPS induced declines in neural stem cell proliferation. PLoS One. 2010;5:e10496.
19. Pabon MM, Jernberg JN, Morganti Josh A. Spirulina-enhanced diet provides neuroprotection in an aα-synuclein model of Parkinson's disease. PLoS One. 2012;7:e45256.
20. Stanicova J, Miskovsky P, Sutiak V. Amantadine: an antiviral and antiparkinsonian agent. Vet Med-Czech. 2001;46:244-56.
21. Lorenc-Koci E, Czarnecka A, Lenda T, Kaminska K, Konieczny J. Molsidomine, a nitric oxide donor, modulates rotational behavior and monoamine metabolism in 6-OHDA lesioned rats treated chronically with L-DOPA. Neurochem Int. 2013;63:790-803.
22. Paxinos G, Watson C. The Rat Brain Stereotaxic Coordinates. San Diego: Academic Press; 1986.
23. Iancu R, Mohapel P, Brundin P. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice. Behav Brain Res. 2005;162:1-10.
24. Utley HC, Bernheim F, Hochslein P. Effect of sulfhydryl reagent on peroxidation in microsomes. Arch Biochem Biophys. 1967;118:29-32.
25. Jollow DJ, Mitchell JR, Zampagloine N. Bromobenzene-induced liver necrosis: protective role of glutathione and evidence for 3, 4 bromobenzene oxide as the hepatotoxic intermediate. Pharmacology. 1974;11:151-69.
26. DeVito MJ, Wagner GC. Methamphetamine-induced neuronal damage: a possible role for free radicals. Neuropharmacology. 1989;28:1145-50.
27. Zafar KS, Sayeed I, Siddiqui A. Dose-dependent protective effect of selenium in partial lesion model of Parkinson's disease: neurobehavioral and neurochemical evidences. J Neurochem. 2003;84:438-46.
28. Zafar KS, Siddiqui A, Sayeed I. Protective effect of adenosine in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences. J Chem Neuroanat. 2003;26:143-51.
29. Kirik D, Rosenblad C, Bjorklund A. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat. Exp Neurol. 1998;152:259-77.
30. Ungerstedt U. Postsynaptic super sensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl. 1971;367:69-93.
31. Przedborski S, Levivier M, Jiang H. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience. 1995;67:631-47.
32. Smith MP, Cass WA. Oxidative stress and dopamine depletion in an intrastriatal 6-hydroxydopamine model of parkinson's disease. Neuroscience. 2007;144:1057-66.
33. Calabrese V, Scapagnini G, Ravagna A, Colombrita C, Spadaro F, Butterfield DA, et al. Increased expression of heat shock proteins in rat brain during aging: relationship with mitochondrial function and glutathione redox state. Mech Ageing Dev. 2004;125:325-35.
34. Sauer H, Oertel WH. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience. 1994;59:401-15.
35. Kramer BC, Mytilineou C. Alterations in the cellular distribution of bcl-2, bcl-x and bax in the adult rat substantia nigra following striatal 6-hydroxydopamine lesions. J Neurocytol. 2004;33:213-23.
36. Sutachan JJ, Casas Z, Albarracin SL. Cellular and molecular mechanisms of antioxidants in Parkinson's disease. Nutr Neurosci. 2012;15:120-6.
37. Butterfield DA, Castegna A, Drake J. Vitamin E and neurodegenerative disorders associated with oxidative stress. Nutr Neurosci. 2002;5:229-39.
38. De Lorgeril M, Renaud S, Salen P. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet. 1994;343:1454-9.
39. Trichopoulou A, Costacou T, Bamia C. Adherence to a Mediterranean diet and survival in a Greek population. Vasc Med. 2004;348:2599-608.
40. Willet WC, Sacks F, Trichopoulou A. Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr. 1995;61:1402-6.
41. Bickford P, Shukitt-Hale B, Joseph J. Effects of aging on cerebellar noradrenergic function and motor learning: nutritional interventions. Mech Ageing Dev. 1999;111:141-54.
42. Bickford PC, Gould T, Briederick L. Antioxidant-rich diets improve cerebellar physiology and motor learning in aged rats. Brain Res. 2000;866:211-7.
43. Joseph JA, Shukitt-Hale B, Denisova NA. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci. 1999;19:8114-21.
44. Joseph JA, Shukitt-Hale B, Denisova NA. Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits. J Neurosci. 1998;18:8047-55.
45. Martin A, Prior R, Shukitt-Hale B. Effects of fruits, vegetables, or vitamin E-rich diet on vitamins E and C distribution in peripheral and brain tissue: implications for brain function. J Gerontol A Biol Sci Med Sci. 2000;55:B144-51.
46. Rehnmark A, Strömberg N. Antioxidant-enriched diet affects early microglia accumulation and promotes regeneration of the striatal dopamine system after a 6-hydroxidopamine-induced lesion in a rat. J Exp Neuroscien. 2012;6:21-32.
47. Sanchez-Pernaute R, Ferree A, Cooper O, Yu M, Brownell AL, Isacson O. Selective COX-2 inhibition prevents progressive dopamine neuron degeneration in a rat model of Parkinson's disease. J Neuroinflammation. 2004;1:6.
48. Angelica PJ, Jorge PR, Norma PC. Neuroprotective effect of Spirulina (Arthrospira) maxima against kainic acid-induced neurotoxicity. J Med Plants Res. 2012;6:206-14.
49. Kalafati M, Jamurtas AZ, Nikoladis MG. Ergogenic and antioxidant effects of spirulina supplementation in humans. Med Sci Sports & Exerc. 2010;42(1):142-51.
50. Roughan PG. Spirulina: a source of dietary gamma-linolenic acid. J of Science of Food and Agriculture. 1989;47:85-93.
51. Skolimowski J, Kochman A, Gebicka L, Metodiewa D. Synthesis and antioxidant activity evaluation of novel antiparkinsonian agents, aminoadamantane derivatives of nitroxyl free radical. Bioorg Med Chem. 2003;11:3529-39.
52. Fourie PM. Neuroprotective effects of amantadine-flavonoid conjugates. NWU Institutional Repository 2011. http://dspace.nwu.ac.za/handle/10394/7339 accessed 30 September 2014.